
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
5 things for parents to know about changes to kids vaccine schedule - 2
Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission. - 3
Step by step instructions to Get a good deal on Your Rooftop Substitution Venture - 4
Washington resident contracts bird flu, first human case in U.S. since February - 5
UAE-backed Yemeni Southern Transitional Council denies disbandment rumors
'Dancing With the Stars' Season 34 finale: Who might win the mirror ball trophy? Where do the remaining contestants rank?
5 Instructive Toy Brands for Youngsters
Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
Amplifying Cash The executives: The Upsides and downsides of Various Ledgers
Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
Kremlin: Russian troops conquer Pokrovsk after year of intense combat
‘Inoculation’ helps people spot political deepfakes, study finds
2 bright planets light up April evenings — here's where and when to look
Danish warship sunk by famed British admiral discovered after 225 years













